Our Press Releases | Association for Accessible Medicines

Access! 2020 - Missed the early-bird? Save $300 off full-pass registration when you register by March 27

Feb 24, 2020 | Rachel Schwartz

AAM and the Biosimilars Council Applaud FDA’s Release of Enhanced Purple Book

Feb 20, 2020 | Rachel Schwartz

Insurers Fail to Get New Generics to America’s Patients

2020 Avalere Analysis Generic Tiers

Feb 13, 2020 | Rachel Schwartz

Avalere Analysis Finds Medicare Part D Patients Are Paying More For Their Lower-Cost Generics

Feb 10, 2020 | Rachel Schwartz

AAM Statement on Resignation of Chip Davis

Feb 6, 2020 | Rachel Schwartz

AAM Announces 2020 Associate Members

Feb 6, 2020 | Rachel Schwartz

AAM Announces 2020 Board of Directors

Feb 5, 2020 | Rachel Schwartz

The Association for Accessible Medicines Wins Public Affairs Council’s Innovations in Public Affairs Award

Jan 29, 2020 | Rachel Schwartz

AAM Statement on Signing USMCA into Law

Jan 23, 2020 | Rachel Schwartz

AAM Statement on Avalere Analysis of Generic Substitution

Jan 16, 2020 | Rachel Schwartz

AAM Statement on Senate Passage of USMCA Agreement

Jan 8, 2020 | Rachel Schwartz

AAM Statement on "The Unintended Economics of the BLOCKING Act" Report

Jan 7, 2020 | Rachel Schwartz

Katherine Michelle Raab Joins AAM as Vice President, Federal Government Affairs